126 related articles for article (PubMed ID: 22343132)
1. Stability and aerosolization of pressurized metered dose inhalers containing thymopentin nanoparticles produced using a bottom-up process.
Tan Y; Yang Z; Pan X; Chen M; Feng M; Wang L; Liu H; Shan Z; Wu C
Int J Pharm; 2012 May; 427(2):385-92. PubMed ID: 22343132
[TBL] [Abstract][Full Text] [Related]
2. Insulin nanoparticles: stability and aerosolization from pressurized metered dose inhalers.
Nyambura BK; Kellaway IW; Taylor KM
Int J Pharm; 2009 Jun; 375(1-2):114-22. PubMed ID: 19481697
[TBL] [Abstract][Full Text] [Related]
3. Moisture uptake and its influence on pressurized metered-dose inhalers.
Williams RO; Hu C
Pharm Dev Technol; 2000; 5(2):153-62. PubMed ID: 10810745
[TBL] [Abstract][Full Text] [Related]
4. Anhydrous reverse micelle nanoparticles: new strategy to overcome sedimentation instability of peptide-containing pressurized metered-dose inhalers.
Huang Z; Wu H; Yang B; Chen L; Huang Y; Quan G; Zhu C; Li X; Pan X; Wu C
Drug Deliv; 2017 Nov; 24(1):527-538. PubMed ID: 28181839
[TBL] [Abstract][Full Text] [Related]
5. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
[TBL] [Abstract][Full Text] [Related]
6. The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers.
Liao YH; Brown MB; Jones SA; Nazir T; Martin GP
Int J Pharm; 2005 Nov; 304(1-2):29-39. PubMed ID: 16181753
[TBL] [Abstract][Full Text] [Related]
7. Development of Aggregation-Caused Quenching Probe-Loaded Pressurized Metered-Dose Inhalers with Fluorescence Tracking Potentials.
Wang W; Huang Z; Xue K; Li J; Wang W; Ma J; Ma C; Bai X; Huang Y; Pan X; Wu C
AAPS PharmSciTech; 2020 Oct; 21(8):296. PubMed ID: 33099699
[TBL] [Abstract][Full Text] [Related]
8. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers.
Smyth HD; Hickey AJ
AAPS PharmSciTech; 2003; 4(3):E38. PubMed ID: 14621970
[TBL] [Abstract][Full Text] [Related]
9. Crosslinked chitosan nanoparticle formulations for delivery from pressurized metered dose inhalers.
Sharma K; Somavarapu S; Colombani A; Govind N; Taylor KM
Eur J Pharm Biopharm; 2012 May; 81(1):74-81. PubMed ID: 22245573
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of novel reverse microemulsions containing salmon calcitonin in hydrofluoroalkane propellants.
Shan Z; Tan Y; Qin L; Li G; Pan X; Wang Z; Yu X; Wang Q; Wu C
Int J Pharm; 2014 May; 466(1-2):390-9. PubMed ID: 24657140
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting the stability and performance of ipratropium bromide; fenoterol hydrobromide pressurized-metered dose inhalers.
Ninbovorl J; Sawatdee S; Srichana T
AAPS PharmSciTech; 2013 Dec; 14(4):1294-302. PubMed ID: 23975571
[TBL] [Abstract][Full Text] [Related]
12. The effect of reduction of propellant mass fraction on the injection profile of metered dose inhalers.
Ju D; Shrimpton J; Hearn A
Int J Pharm; 2010 May; 391(1-2):221-9. PubMed ID: 20227471
[TBL] [Abstract][Full Text] [Related]
13. Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystals.
Murnane D; Martin GP; Marriott C
Pharm Res; 2008 Oct; 25(10):2283-91. PubMed ID: 18509598
[TBL] [Abstract][Full Text] [Related]
14. Novel pMDI formulations for pulmonary delivery of proteins.
Li HY; Seville PC
Int J Pharm; 2010 Jan; 385(1-2):73-8. PubMed ID: 19854252
[TBL] [Abstract][Full Text] [Related]
15. Impact of droplet evaporation rate on resulting in vitro performance parameters of pressurized metered dose inhalers.
Sheth P; Grimes MR; Stein SW; Myrdal PB
Int J Pharm; 2017 Aug; 528(1-2):360-371. PubMed ID: 28599855
[TBL] [Abstract][Full Text] [Related]
16. Sub-micrometer particle production by pressurized metered dose inhalers.
Crampton M; Kinnersley R; Ayres J
J Aerosol Med; 2004; 17(1):33-42. PubMed ID: 15120011
[TBL] [Abstract][Full Text] [Related]
17. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
Williams RO; Repka M; Liu J
Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
[TBL] [Abstract][Full Text] [Related]
18. On the Feasibility of Rugose Lipid Microparticles in Pressurized Metered Dose Inhalers with Established and New Propellants.
Minootan Z; Wang H; Connaughton P; Lachacz K; Carrigy N; Ordoubadi M; Lechuga-Ballesteros D; Martin AR; Vehring R
AAPS PharmSciTech; 2024 Apr; 25(4):82. PubMed ID: 38600288
[TBL] [Abstract][Full Text] [Related]
19. Humidity affects the morphology of particles emitted from beclomethasone dipropionate pressurized metered dose inhalers.
Ivey JW; Bhambri P; Church TK; Lewis DA; McDermott MT; Elbayomy S; Finlay WH; Vehring R
Int J Pharm; 2017 Mar; 520(1-2):207-215. PubMed ID: 28167262
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
